Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial
Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of mental health care with psilocybin, is pleased to its approval by Health Canada to begin APEX-002-A01-03.